These findings contrast with the expression of CXCL17 detected in the lung of COVID-19 patients, suggesting that the levels of CXCL17 in serum and its expression in lung tissue specimens do not correlate during the course of the disease. The gene discussed is CXCL17; the disease is COVID-19.